Thus, the aim of this study is to investigate the clinical significance of FGFR1, FGFR2, FGFR3 and FGFR4 expression in a well-defined cohort of cervical cancers, using immunohistochemistry and quantitative digital image analysis. The gene discussed is FGFR2; the disease is cervical carcinoma.